-
Patients Without Traditional Cancer Screening Find Allies In Maccabi And Medial EarlySign
Sep 8, 2017, 08:45 AM by Michael CroftFull storyBio-IT World | 2017 Best Practices Awards | Maccabi Healthcare System is using Medial EarlySign’s clinical decision support tool to find colon cancer patients among individuals who didn’t go through traditional channels for screening.
-
Visualising gene-trait networks for faster discovery
Sep 8, 2017, 07:57 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Sep 8, 2017 - It is now possible for non-bioinformaticians to create knowledge-networks – a powerful way for biologists to visualise deep connections between genes and phenotypes – quickly and efficiently thanks to the integration of Rothamsted Researchs open-source KnetMiner software into the Genestack platformFull story -
Does Your Genome Predict Your Face? Not Quite Yet
Sep 7, 2017, 12:50 PM by Michael CroftMIT Technology Review | Genomics pioneer J. Craig Venter says if he had your genome he could pick you out of a crowd. According to two experts who reviewed the famed genomics expert's claim, however, that's not necessarily true.Full story -
BioIVT Acquires Qualyst Transporter Solutions, Enables Researchers to Predict New Drug Candidates’ Impact on the Liver
Sep 7, 2017, 12:28 PM by Michael CroftWESTBURY, NY - Sep 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it has acquired Qualyst Transporter Solutions, LLCFull story -
At Vanderbilt, NCI’s Cooperative Human Tissue Network Relies On Lean Principles For Efficiency
Sep 7, 2017, 09:15 AM by Michael CroftFull storyBio-IT World | The National Cancer Institute’s Cooperative Human Tissue Network (CHTN) provides human tissues and fluids from routine procedures to investigators who use human biospecimens in their research. Unlike tissue banks, the CHTN works prospectively with each investigator to tailor specimen acquisition and processing to meet their specific project requirements.
-
IBM Pitched Watson As A Revolution In Cancer Care. It's Nowhere Close
Sep 6, 2017, 11:35 AM by Michael CroftSTAT | Three years after IBM began selling Watson for Oncology to recommend cancer treatments, it's falling short of the lofty expectations IBM created for it.Full story -
FormulationX To Debut At INTERPHEX 2018; Elsevier A Foundation Sponsor
Sep 6, 2017, 05:18 AM by Michael CroftNEW YORK, NY - Sep 5, 2017 - International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut at INTERPHEX 2018 featuring exhibits, technical conference and networking focused on drug substanceFull story -
Human Longevity Researchers Use Whole Genome Sequence Data And Machine Learning To Identify Individuals Through Face And Other Physical Trait Prediction
Sep 5, 2017, 10:50 AM by Michael CroftFull storyBio-IT World Brief | Researchers from Human Longevity have published a study in which individual faces and other physical traits were predicted using whole genome sequencing data and machine learning. This work was published in the journal Proceedings from the National Academy of Sciences.
-
MR Solutions receives second Queen’s Award from Lord-Lieutenant of Surrey
Sep 4, 2017, 11:31 AM by Michael Croft, UNITED KINGDOM - Sep 4, 2017 - MR Solutions has received the prestigious Queens Award for Enterprise from the Lord-Lieutenant of Surrey at their Guildford headquarters in September in recognition of their outstanding success in growing international salesFull story -
GenePattern Notebook Environment Needs Only A Web Browser To Run Analyses
Aug 31, 2017, 16:05 PM by Michael CroftBio-IT World Researchers at the University of California San Diego School of Medicine and the Broad Institute of MIT and Harvard have launched a new GenePattern Notebook environment, which combines the dynamic capabilities of an electronic analysis notebook with the ease of use of a point-and-click interface to hundreds of genomic tools.Full story -
Renewed Attention Sees New Progress For Hepatitis B
Aug 31, 2017, 11:40 AM by Michael CroftFull storyBio-IT World | The HBV field has seen increased attention from industry research in the past few years, influenced by the success of new hepatitis C virus (HCV) therapies. After scientists realized HCV could be cured, they turned their attention to hepatitis B, hoping to develop a cure for it also.
-
FDA Approval Brings First Gene Therapy To The United States
Aug 30, 2017, 17:35 PM by Michael CroftFull storyBio-IT World Brief | The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
-
Edico, DNAnexus Launch $20, 90-minute Whole Genome Analysis
Aug 30, 2017, 16:20 PM by Michael CroftBio-IT World Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome’s DRAGEN on Amazon Web Service’s EC2 F1/FPGA instances via DNAnexus. For a limited time, the cost to analyze a whole genome at 35X coverage will be $20 and take about an hour and a half, Pieter van Rooyen said.Full story -
Seven Bridges, Numerate, The Wellcome Trust Sanger Institute, And More: News From August 2017
Aug 30, 2017, 09:55 AM by Michael CroftFull storyBio-IT World | August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Seven Bridges, Numerate, the Wellcome Trust Sanger Institute, and more.
-
Freenome Announces Series A Extension Led By Section 32
Aug 28, 2017, 16:38 PM by Michael CroftDiagnostics World News | Freenome announced that it has raised an additional $7 million as an extension to its previously announced Series A funding, bringing the total to nearly $72 million. The extension was led by Section 32.Full story -
New ZEISS Celldiscoverer 7 for Live Cell Imaging
Aug 28, 2017, 12:05 PM by Michael CroftPEABODY, MA - Aug 28, 2017 - ZEISS introduces a new system for automated microscopy in life sciences research. ZEISS Celldiscoverer 7 combines the user-friendly automation features of a boxed microscope with the image quality and flexibility of a classic inverted research microscopeFull story -
Gilead Agrees To Buy Kite Pharma, Leaping Into CAR-T Cancer Therapy
Aug 28, 2017, 10:57 AM by Michael CroftSTAT | Gilead agrees to buy Kite Pharma and its emerging line of CAR-T oncology therapies, which aim to harnesses the immune system to fight cancer.Full story -
LifeSphere Intake and Triage™ Leverages Automation to Significantly Improve Efficiency of Safety Case Intake Process, Eliminating 90% of Manual Data Entry
Aug 28, 2017, 06:13 AM by Michael CroftCHICAGO, IL, UNITED STATES - Aug 30, 2017 - ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences, announces LifeSphere Intake and Triage™, a sophisticated case triage solution that enables drug and device companies to manage the intake, receipt and triaging of adverse events (AEs) automatically from a wide range of sources, including email, fax, online portal, electronic gateway (capable of processing both E2B (R3) and E2B (R2) cases) and mobile appsFull story -
Reltio Named to Inc. 5000 List of America’s Fastest-Growing Private Companies
Aug 25, 2017, 18:07 PM by Michael CroftNEW YORK, NY - Aug 25, 2017 - Inc. Magazine has ranked Reltio No. 153 on its 36th annual Inc. 5000, the most prestigious ranking of the nation's fastest-growing private companiesFull story -
Allotrope Foundation: A Framework For Knowledge Management
Aug 25, 2017, 09:25 AM by Michael CroftFull storyBio-IT World | 2017 Best Practices Awards | The Allotrope Foundation hopes their Allotrope Framework will allow researchers to rethink the way they acquire and manage scientific data.